Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Lisdexamfetamine Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Capsule
  • 1.4.3 Chewable Tablet
• 1.5 Market by Application
  • 1.5.1 Global Lisdexamfetamine Market Share by Application (2014-2025)
  • 1.5.2 ADHD in Adults
  • 1.5.3 ADHD in Children
  • 1.5.4 B.E.D. in Adults
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Lisdexamfetamine Market Size
• 2.2 Lisdexamfetamine Growth Trends by Regions
  • 2.2.1 Lisdexamfetamine Market Size by Regions (2014-2025)
  • 2.2.2 Lisdexamfetamine Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Lisdexamfetamine Market Size by Manufacturers
  • 3.1.1 Global Lisdexamfetamine Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Lisdexamfetamine Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Lisdexamfetamine Market Concentration Ratio (CR5 and HHI)
• 3.2 Lisdexamfetamine Key Players Head office and Area Served
• 3.3 Key Players Lisdexamfetamine Product/Solution/Service
• 3.4 Date of Enter into Lisdexamfetamine Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Lisdexamfetamine Market Size by Type (2014-2019)
• 4.2 Global Lisdexamfetamine Market Size by Application (2014-2019)

5 United States

• 5.1 United States Lisdexamfetamine Market Size (2014-2019)
• 5.2 Lisdexamfetamine Key Players in United States
• 5.3 United States Lisdexamfetamine Market Size by Type
• 5.4 United States Lisdexamfetamine Market Size by Application

6 Europe

• 6.1 Europe Lisdexamfetamine Market Size (2014-2019)
• 6.2 Lisdexamfetamine Key Players in Europe
• 6.3 Europe Lisdexamfetamine Market Size by Type
• 6.4 Europe Lisdexamfetamine Market Size by Application

7 China

• 7.1 China Lisdexamfetamine Market Size (2014-2019)
• 7.2 Lisdexamfetamine Key Players in China
• 7.3 China Lisdexamfetamine Market Size by Type
• 7.4 China Lisdexamfetamine Market Size by Application

8 Japan

• 8.1 Japan Lisdexamfetamine Market Size (2014-2019)
• 8.2 Lisdexamfetamine Key Players in Japan
• 8.3 Japan Lisdexamfetamine Market Size by Type
• 8.4 Japan Lisdexamfetamine Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Lisdexamfetamine Market Size (2014-2019)
• 9.2 Lisdexamfetamine Key Players in Southeast Asia
• 9.3 Southeast Asia Lisdexamfetamine Market Size by Type
• 9.4 Southeast Asia Lisdexamfetamine Market Size by Application

10 India

• 10.1 India Lisdexamfetamine Market Size (2014-2019)
• 10.2 Lisdexamfetamine Key Players in India
• 10.3 India Lisdexamfetamine Market Size by Type
• 10.4 India Lisdexamfetamine Market Size by Application

11 Central & South America

• 11.1 Central & South America Lisdexamfetamine Market Size (2014-2019)
• 11.2 Lisdexamfetamine Key Players in Central & South America
• 11.3 Central & South America Lisdexamfetamine Market Size by Type
• 11.4 Central & South America Lisdexamfetamine Market Size by Application

12 International Players Profiles

• 12.1 Shire
  • 12.1.1 Shire Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Lisdexamfetamine Introduction
  • 12.1.4 Shire Revenue in Lisdexamfetamine Business (2014-2019)
  • 12.1.5 Shire Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Lisdexamfetamine (contracted from L-lysine-dextroamphetamine) is a substituted amphetamine and an inactive prodrug of the central nervous system (CNS) stimulant dextroamphetamine that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and binge eating disorder.
In 2018, the global Lisdexamfetamine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lisdexamfetamine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lisdexamfetamine development in United States, Europe and China.

The key players covered in this study
Shire
...

Market segment by Type, the product can be split into
Capsule
Chewable Tablet

Market segment by Application, split into
ADHD in Adults
ADHD in Children
B.E.D. in Adults

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lisdexamfetamine status, future forecast, growth opportunity, key market and key players.
To present the Lisdexamfetamine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lisdexamfetamine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.